Comment

  • 11 January 2019

    Observations from GCP Sponsor Inspections

    Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has observed in various GCP inspections

  • 10 December 2018

    How to Enable Greater Budget Forecasting

    Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model of budget transparency with CROs to enable better budget forecasting

  • 30 November 2018

    The United Kingdom of Green Britain

    As medicinal cannabis hits the U.K., CTA’s Harry Parsons takes a look at the ground-breaking reform taking place and how it could impact clinical research

Go Top